Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
environment for the pursuit of cutting-edge cardiovascular and metabolic research (https://www.kcl.ac.uk/scms ). We study the fundamental molecular, cellular, and physiological processes that underly normal and
-
The Department of Molecular Biology, Umeå University, Sweden, seeks a postdoctoral researcher to pursue a project in single cell transcriptomics of microorganisms. The employment is full-time for
-
available in the Pan Hammarström Lab (https://ki.se/en/research/groups/pan-hammarstrom-lab ), which is part of the Division of Immunology under the Department of Medical Biochemistry and Biophysics
-
to the development of large-scale bone tissue implants. Beyond a certain size, sufficient vascularization of the implant is essential to enable the formation of functional bone tissue and to reduce cell necrosis
-
Department: Tomáš Bárta Research Group: Stem Cell Biology and Vision Research – Faculty of Medicine Deadline: 31 Jan 2026 Start date: April 2026 or upon agreement Job type: full-time Job field
-
influenced mineralization without a specific cell signature – and to differentiate them from biosignatures, which are unequivocal evidence of life. Through laboratory studies, this research aims to produce a
-
perform these reactions alone, strong and well-coordinated interactions between multiple species are essential. As a doctoral student in this project, you will investigate cell communication in
-
multiple species are essential. As a doctoral student in this project, you will investigate cell communication in these closely interacting microbial communities. By combining advanced anaerobic cultivation
-
hours/week. Interns will earn $17.50-$21.50/hour. This role is hybrid in Boston. Specific work hours will be determined by the supervisor. What you'll do Assist in the setup and operation of simulator
-
Instituto de Investigação e Inovação em Saúde da Universidade do Porto (i3S) | Portugal | about 1 month ago
regulation and lymphoma pathogenesis, has emerged as a promising candidate. We showed that PSGL-1 blockade with a monoclonal antibody (mAb) enhances T cell activation, alters the lymphoma immune